SCHEMBL18619573

SCHEMBL18619573

N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OCc1ccccc1)c1ccccc1)C(=O)CF

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MALT1 Q9UDY8 1/20 0.53
▸ DPP4 P27487 2/20 0.44
▸ DPP8 Q6V1X1 2/20 0.44
▸ DPP9 Q86TI2 1/20 0.44
▸ DPP7 Q9UHL4 1/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ ACE P12821 1/20 0.43
▸ CYP3A4 P08684 6/20 0.42
▸ CYP2C9 P11712 4/20 0.42
▸ CYP2C19 P33261 4/20 0.42
▸ CYP2D6 P10635 2/20 0.42
▸ OPRM1 P35372 1/20 0.42
▸ OPRD1 P41143 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ CYP1A2 P05177 2/20 0.41
▸ CASP3 P42574 3/20 0.41
▸ TMPRSS11D O60235 1/20 0.41
▸ F2 P00734 1/20 0.41
▸ F10 P00742 1/20 0.41
▸ PLG P00747 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18619574 0.93 MALT1 (0.52) MALT1DPP4DPP8DPP9DPP7
SCHEMBL18619567 0.93 MALT1 (0.52) MALT1DPP4DPP8DPP9DPP7
SCHEMBL22209464 0.91 MALT1 (0.57) MALT1DPP4DPP8DPP9DPP7
SCHEMBL18619636 0.91 MALT1 (0.55) MALT1DPP4DPP8ACEOPRM1
SCHEMBL20485185 0.89 MALT1 (0.43) MALT1KCNH2CYP3A4CYP2C9CYP2C19
SCHEMBL20485183 0.89 MALT1 (0.43) MALT1KCNH2CYP3A4CYP2C9CYP2C19
SCHEMBL20485181 0.89 MALT1 (0.43) MALT1KCNH2CYP3A4CYP2C9CYP2C19
SCHEMBL22209365 0.89 MALT1 (0.64) MALT1CMA1
SCHEMBL18619572 0.89 MALT1 (0.64) MALT1CMA1
SCHEMBL22811073 0.89 MALT1 (0.64) MALT1CMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3341007-B1 MALT1 INHIBITORS AND USES THEREOF UNIV CORNELL (US) 2020-12-23 — — EP disclosed
US-10711036-B2 MALT1 inhibitors and uses thereof CORNELL UNIVERSITY (US) 2020-07-14 — — US disclosed
WO-2017040304-A1 MALT1 INHIBITORS AND USES THEREOF CORNELL UNIVERSITY (US) 2017-03-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10711036-B2 MALT1 inhibitors and uses thereof MALT1, BCL3, BCL6 MALT1 1/4885DPP4 2242/4885DPP8 1846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback